Health System

Emerging research on therapeutics and practical approaches to managing a myriad of dermatological conditions, as well as a growing focus on diversity, equity, and inclusion will be explored at the 2022 American Academy of Dermatology (AAD) Annual Meeting, which will take place March 25-29, in Boston, Massachusetts.

Lalan Wilfong, MD, vice president of Payer Relations & Practice Transformation at The US Oncology Network, speaks on how use of health economics and outcomes research has benefitted patient care in the community oncology setting and where it can be further leveraged in the pursuit of value-based care.

Jim Schwartz, RPh, corporate pharmacy manager, Texas Oncology, discussed pharmacy challenges regarding equitable care and distribution of specialty drugs in the community oncology setting.

Addressing avoidable emergency department (ED) utilization takes interventions in partnership with providers.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Ben Jones, vice president, Government Relations & Public Policy, The US Oncology Network, addresses potential reform at the federal and state level that could accelerate the pursuit of value-based care in the community oncology setting.

Michael Diaz, MD, president and managing physician, Florida Cancer Specialists & Research Institute, speaks on takeaways from his discussions on site of care and pharmacy benefit managers (PBMs) at the 2022 Community Oncology Conference.

Medicare advantage beneficiaries who received care from providers in 2-sided risk payment models had lower rates of acute care use, according to new study findings.

The study called for increased education, productive health care professional dialogue, and shared decision-making in the management of patients with psoriasis and psoriatic arthritis.

Along with common symptoms of itch and pain, patients with atopic dermatitis experience significant work productivity and attention issues that affect overall quality of life, said Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital.

FDA issued a complete response letter (CRL) to AstraZeneca seeking additional clinical data for benralizumab, sold as Fasenra, in the treatment of patients with inadequately controlled chronic rhinosinusitis with nasal polyps.

Idaho legislature passed Texas-inspired abortion law banning the procedure after 6 weeks of pregnancy; patients who were bedridden with severe cases of COVID-19 had increased risks of anxiety and depression more than a year later; number of deaths by suicide in Japanese women rose for second straight year.

Longer-term findings of the Measure Up 1 and 2 studies showed the JAK inhibitor upadacitinib to be safe and effective after 52 weeks in the treatment of adults and adolescents with moderate to severe atopic dermatitis.

Cardiac troponin I (cTnI) and N-terminal pro-brain-type natriuretic peptide (NT-proBNP) were associated with incident cardiovascular events in patients with psoriatic disease.

The FDA based its approval on OlympiA trial data, which show the PARP inhibitor has the ability to reduce risks of invasive breast cancer recurrence, second cancers, and death, and to improve overall survival.

Screening for colorectal cancer is an urgent priority for Americans aged 45 and older; low COVID-19 vaccine uptake was observed among US children aged 5 to 11 years in the first weeks of eligibility; WHO warns of increased alcohol consumption risk due to the pandemic.

Kashyap Patel, MD, chief executive officer, Carolina Blood and Cancer Care Associations, and current president of the Community Oncology Alliance (COA), previews his discussion on health equity to be held at the 2022 Community Oncology Conference.

Patients with chronic rhinosinusitis (CRS) with severe radiographic disease were more likely to report incidence of nasal polyps and be managed by endoscopic sinus surgery, but did not show greater health care utilization.

A retrospective, quasi-experimental study found that patients admitted to the intensive care unit (ICU) for acute respiratory failure (ARF) saw better outcomes when an inter-ICU transfer came within the first 2 days of admittance.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Soumya Chakravarty, MD, PhD, FACP, FACR, strategic lead, Rheumatology Therapeutic Area at Janssen, spoke on adverse patient outcomes caused by diagnostic delays in psoriatic arthritis and progress made to address this unmet need.

David Penberthy, MD, MBA, medical director of radiation oncology at Southside Regional Medical Center, discusses his theme as president-elect of the Association of Community Cancer Centers (ACCC) and what initiatives and discussions he looks forward to addressing over the next year.

Reasons for pursuing genomic profiling among patients with advanced bladder, renal, and prostate cancers included guiding treatment and improving treatment response, in which age and education level were found to significantly influence shared decision-making.

This study presents a methodology for forecasting demand of COVID-19 on health resources in an integrated health system.

Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who have comorbidities were more likely than those without co-occuring conditions to require revision endoscopic sinus surgery over a 10-year period.

For the second straight month, national telehealth utilization, measured as a percentage of all medical claim lines, grew in December 2021, according to FAIR Health’s Monthly Telehealth Regional Tracker.

Data from 2015 show approximately half of US-born adults were exposed to harmful levels of lead as children; Florida’s Department of Health to advise against COVID-19 vaccination for "healthy" children; Black patients remain underrepresented in clinical trials for newly approved drugs despite FDA efforts.

Japanese patients with psoriasis reported improved objective symptoms and satisfaction with brodalumab.

A significant increase has been observed in Texas residents traveling out of state for abortion care; nearly a third of people who previously had COVID-19 cited lingering symptoms up to 1 year after infection; muscle strengthening exercises linked with lower risk of disease and early mortality.

A new report from the CDC details how services for HIV, sexual health, and viral hepatitis were affected in the aftermath of the COVID-19 pandemic, according to data from 2019 and 2020.